Two RNA-binding proteins could contribute to cancer therapy development
The paper identifies the roles and differences between LARP4A and LARP4B in sarcoma and carcinoma cancers
Read More
Tag: sarcoma
First patient dosed in Immutep’s soft tissue sarcoma trial
The phase 2 study involves company’s eftilagimod alpha therapy
Read More
Merck’s Keytruda, Lilly’s Lartruvo available via CDF
Patients with certain forms of lung cancer or sarcoma have now gained access to two new treatment options on the NHS in England after Merck’s Keytruda and Eli Lilly’s Lartruvo were added to the Cancer Drugs Fund.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
